How do we identify and measure value for patients with rare diseases?
Authors: Annie Kennedy and Joff Masukawa. Rare diseases impact 1 in 10 Americans, and over 400 million people worldwide. The current development and FDA approval process can cost hundreds of millions of dollars – and [...]
PRESS RELEASE: IVI Announces Grant to National Health Council, National Alliance of Healthcare Purchaser Coalitions to Improve Value Assessment
Goal: Identify Areas of Consensus to Ultimately Make the Value Assessment Process Useful to Those Who Receive and Pay for Care Alexandria, VA – July 20, 2020 – The Innovation and Value Initiative (IVI), a [...]
How IVI Puts Patients at the Center of Value Assessment
Central to IVI’s work is ensuring patient perspectives are included at the front of all value assessments. This short video explains why and how IVI incorporates lived experience in its modeling.
Can Depression Help Employers Improve Their Value Assessment Methods?
IVI's Jennifer Bright and Mike Thompson of the National Alliance for Healthcare Purchasers share how employers can use depression as a "test case" for thinking about how to improve the value assessment process, so that [...]
Value Assessment During the COVID-19 Pandemic
The COVID-19 pandemic is raising new questions about how we approach value assessment. As always, IVI urges experts to use transparency, real world data, and seek consensus. Sam Nussbaum, President of the IVI Board of [...]
Defining Value Starts with Patients
Authors: Alan Balch and Donna Cryer The vast majority of experts agree that we could, and should, be doing a lot more to include input from patients in value assessment, from conceptualization to data inputs [...]
Why Accounting for Our Differences Matter in Assessing Drug Value
IVI's Jennifer Bright and Amy Miller, former CEO of the Society for Women's Health Research, explain why patient heterogeneity is crucial to consider in any value assessment method. Read the full article here.
Experts Address Gaps in Value Assessment
Previewing their panel discussion at ISPOR 2020, Lou Garrison and Leah Howard discuss what’s needed to address gaps on value assessment. View the short video clip here.
IVI Shares Executive Summary of Annual Methods Summit
The national dialogue on value in health care is bringing to the forefront the limitations of current value assessment methods and gaps in real world data to inform decision-making. IVI seeks to engage a wider [...]
Measuring Value: COVID-19 Forces a Reassessment
Authors: Patricia Deverka, Jennifer Bright, Louis Garrison, Samuel Nussbaum We have seen the COVID-19 pandemic decimate people’s lives, health care systems, and the global and US economy, with investments by the US government exceeding $4 [...]
PRESS RELEASE: Seven High-Profile Patient Engagement Leaders to Advise Nonprofit on its Patient-Focused Research Agenda
Alexandria, VA – May 6, 2020 – The Innovation and Value Initiative (IVI), a research-based non-profit improving the science and practice of value assessment, today announced the appointment of seven members to its Patient Advisory [...]
Patients at the Center of It All
Making our way through a global pandemic will require all the assets and brain power our health system and leaders have to offer. And yet while the pandemic has been a novel disruptor, it has [...]